ISG15 and the enzymes responsible for catalysing ISGylation and deISGylation exhibit dysregulation in different cancer types, such as breast, ovarian, pancreatic, colorectal, glioma, and prostate cancers [49]. The gene discussed is ISG15; the disease is cancer.